North America Dna Vaccine Market Forecast 2017-2025
KEY FINDINGS The North America DNA vaccine market is predicted to flourish with a CAGR of 45.37% for the forecast period of 2017-2025, generating a market share of $9088 million by 2025.
MARKET INSIGHTS The market is segmented according to the type of technology, applications, and DNA vaccine type. Opportunities like the chance to transform the healthcare landscape, along with the ease of storage and transport of these vaccines are profoundly shaping the market growth. The market is especially gaining popularity in the animal healthcare sector as the vaccines help in the insurance and counteractive action for many veterinary diseases. Also, the ongoing clinical trials for human DNA vaccine is considerably propelling the market ahead.
COMPETITIVE INSIGHTS The leading companies in this market are Merck & Co, Madison Vaccines Incorporated (MVI), Glaxosmithkline Inc, Novartis Ag, Xenetic Biosciences Inc, Astellas Pharma Inc, Inovio Pharmaceuticals Inc and Vical Incorporated.